Pathology of preinvasive and excellent-prognosis breast cancer.
Recent advances in breast cancer treatment have made recognition of different prognostic groups mandatory. In addition, further experience with screening-detected lesions has resulted in definition of new associations. Therapeutic approaches to these frequently microscopic lesions are currently the source of much debate. This article reviews recent studies of excellent-prognosis carcinomas, as well as premalignant and other histologically defined lesions that indicate an increased risk for development or recurrence of carcinoma. Advances in fine-needle aspiration and in hormone receptor assays are also reviewed.
Simpson
J F
JF
City of Hope Medical Center, Durate, California.
Page
D L
DL
D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000473:pathology*; D002278:Carcinoma in Situ / Q000473:pathology; D002285:Carcinoma, Intraductal, Noninfiltrating / Q000473:pathology; D005260:Female; D006801:Humans; D009361:Neoplasm Invasiveness; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000032:analysis; D013997:Time Factors
D011956:Receptors, Cell Surface